AstraZeneca Buys Fusion Pharmaceuticals for US$2 B

By Lucy Haggerty

Pharma Deals Review: Vol 2024 Issue 3 (Table of Contents)

Published: 22 Mar-2024

DOI: 10.3833/pdr.v2024.i3.2862     ISSN: 1756-7874

Section: Mergers & Acquisitions



Reinforcing its commitment to transforming cancer treatments, AstraZeneca has agreed to acquire Fusion Pharmaceuticals for an initial value of US$2 B...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details